company background image
ZTS

Zoetis NYSE:ZTS Stock Report

Last Price

US$177.72

Market Cap

US$81.8b

7D

-1.1%

1Y

19.6%

Updated

25 Sep, 2023

Data

Company Financials +

ZTS Stock Overview

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally.

ZTS fundamental analysis
Snowflake Score
Valuation2/6
Future Growth2/6
Past Performance3/6
Financial Health4/6
Dividends0/6

Zoetis Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Zoetis
Historical stock prices
Current Share PriceUS$177.72
52 Week HighUS$194.99
52 Week LowUS$124.15
Beta0.77
1 Month Change-2.79%
3 Month Change4.13%
1 Year Change19.60%
3 Year Change10.17%
5 Year Change93.89%
Change since IPO473.11%

Recent News & Updates

Estimating The Intrinsic Value Of Zoetis Inc. (NYSE:ZTS)

Sep 25
Estimating The Intrinsic Value Of Zoetis Inc. (NYSE:ZTS)

Here's Why Zoetis (NYSE:ZTS) Can Manage Its Debt Responsibly

Sep 04
Here's Why Zoetis (NYSE:ZTS) Can Manage Its Debt Responsibly

Recent updates

Estimating The Intrinsic Value Of Zoetis Inc. (NYSE:ZTS)

Sep 25
Estimating The Intrinsic Value Of Zoetis Inc. (NYSE:ZTS)

Here's Why Zoetis (NYSE:ZTS) Can Manage Its Debt Responsibly

Sep 04
Here's Why Zoetis (NYSE:ZTS) Can Manage Its Debt Responsibly

Zoetis: Pawses Pain, Librela OA Treatment Targets Furry Friends In The U.S.

Aug 22

Should You Be Adding Zoetis (NYSE:ZTS) To Your Watchlist Today?

Aug 12
Should You Be Adding Zoetis (NYSE:ZTS) To Your Watchlist Today?

Zoetis: My Dog Approves Of This Dividend Compounder

Jul 19

Zoetis: A Purrfect Addition To Your Portfolio

Jun 22

Does This Valuation Of Zoetis Inc. (NYSE:ZTS) Imply Investors Are Overpaying?

Jun 10
Does This Valuation Of Zoetis Inc. (NYSE:ZTS) Imply Investors Are Overpaying?

These 4 Measures Indicate That Zoetis (NYSE:ZTS) Is Using Debt Reasonably Well

Apr 16
These 4 Measures Indicate That Zoetis (NYSE:ZTS) Is Using Debt Reasonably Well

Estimating The Intrinsic Value Of Zoetis Inc. (NYSE:ZTS)

Mar 10
Estimating The Intrinsic Value Of Zoetis Inc. (NYSE:ZTS)

Zoetis rises on 2023 revenue forecast above estimates, Q4 profit in-line with consensus

Feb 14

Zoetis Is An Awesome Dividend Growth Stock

Jan 17

It's A Great Time To Buy Zoetis Shares

Jan 10

Zoetis' (NYSE:ZTS) Upcoming Dividend Will Be Larger Than Last Year's

Jan 03
Zoetis' (NYSE:ZTS) Upcoming Dividend Will Be Larger Than Last Year's

Is Zoetis (NYSE:ZTS) Using Too Much Debt?

Dec 29
Is Zoetis (NYSE:ZTS) Using Too Much Debt?

Zoetis' (NYSE:ZTS) Upcoming Dividend Will Be Larger Than Last Year's

Dec 14
Zoetis' (NYSE:ZTS) Upcoming Dividend Will Be Larger Than Last Year's

Zoetis raises quarterly dividend by 15.4% to $0.375/share

Dec 08

Estimating The Fair Value Of Zoetis Inc. (NYSE:ZTS)

Nov 20
Estimating The Fair Value Of Zoetis Inc. (NYSE:ZTS)

Zoetis' Q3 Earnings: Supply Issues Putting A Dent On Growth

Nov 08

Zoetis Q3 2022 Earnings Preview

Nov 02

Does Zoetis (NYSE:ZTS) Deserve A Spot On Your Watchlist?

Nov 02
Does Zoetis (NYSE:ZTS) Deserve A Spot On Your Watchlist?

Zoetis declares $0.325 dividend

Oct 13

A Rising Dollar May Mean Lower Zoetis Shares

Oct 07

Is Zoetis (NYSE:ZTS) Using Too Much Debt?

Sep 15
Is Zoetis (NYSE:ZTS) Using Too Much Debt?

Zoetis cleared to acquire Jurox in Australia subject to divestiture

Sep 15

Zoetis acquires Scottish animal health digital tech business

Sep 05

Are Investors Undervaluing Zoetis Inc. (NYSE:ZTS) By 21%?

Aug 19
Are Investors Undervaluing Zoetis Inc. (NYSE:ZTS) By 21%?

Zoetis: Strong Q2 Underlying Growth But Hit By Strong U.S. Dollar

Aug 12

Zoetis Q2 2022 Earnings Preview

Aug 03

Zoetis: Lovable Company With Vision

Jul 20

Here's Why We Think Zoetis (NYSE:ZTS) Is Well Worth Watching

Jul 04
Here's Why We Think Zoetis (NYSE:ZTS) Is Well Worth Watching

Is Zoetis (NYSE:ZTS) Using Too Much Debt?

Jun 17
Is Zoetis (NYSE:ZTS) Using Too Much Debt?

Zoetis: Animal Health Leader Now Cheapest Since April 2021

May 20

An Intrinsic Calculation For Zoetis Inc. (NYSE:ZTS) Suggests It's 21% Undervalued

May 17
An Intrinsic Calculation For Zoetis Inc. (NYSE:ZTS) Suggests It's 21% Undervalued

Why You Might Want To Add Zoetis To Your Portfolio

Apr 13

Here's Why I Think Zoetis (NYSE:ZTS) Might Deserve Your Attention Today

Mar 26
Here's Why I Think Zoetis (NYSE:ZTS) Might Deserve Your Attention Today

Zoetis: Upgrade To Buy After 22% Fall From Peak And Strong Q4

Feb 18

Estimating The Fair Value Of Zoetis Inc. (NYSE:ZTS)

Feb 09
Estimating The Fair Value Of Zoetis Inc. (NYSE:ZTS)

Shareholder Returns

ZTSUS PharmaceuticalsUS Market
7D-1.1%-2.0%-2.7%
1Y19.6%11.9%16.8%

Return vs Industry: ZTS exceeded the US Pharmaceuticals industry which returned 10.8% over the past year.

Return vs Market: ZTS exceeded the US Market which returned 15.1% over the past year.

Price Volatility

Is ZTS's price volatile compared to industry and market?
ZTS volatility
ZTS Average Weekly Movement3.6%
Pharmaceuticals Industry Average Movement9.5%
Market Average Movement5.5%
10% most volatile stocks in US Market14.2%
10% least volatile stocks in US Market2.5%

Stable Share Price: ZTS is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: ZTS's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
195213,800Kristin Peckhttps://www.zoetis.com

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. The company also offers parasiticides; vaccines; anti-infectives; other pharmaceutical products; dermatology; and medicated feed additives.

Zoetis Inc. Fundamentals Summary

How do Zoetis's earnings and revenue compare to its market cap?
ZTS fundamental statistics
Market CapUS$81.81b
Earnings (TTM)US$2.21b
Revenue (TTM)US$8.22b

37.0x

P/E Ratio

9.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
ZTS income statement (TTM)
RevenueUS$8.22b
Cost of RevenueUS$2.45b
Gross ProfitUS$5.78b
Other ExpensesUS$3.56b
EarningsUS$2.21b

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)4.81
Gross Margin70.24%
Net Profit Margin26.92%
Debt/Equity Ratio142.6%

How did ZTS perform over the long term?

See historical performance and comparison

Dividends

0.8%

Current Dividend Yield

29%

Payout Ratio